Psychiatrist Challenges Ethics of Yale Drug Experiment

The ethics of this radical drug experiment is being challenged by Dr. Jerald Block, a forthright psychiatrist and experienced system's analyst. His critical appraisal, published in the Bioethics Forum, Hastings Center Report. Continue reading →

Antipsychotics Killed at least 45 Children_FDA Not Concerned –USA Today

 "I trusted the doctors, I trusted the FDA … and I feel betrayed by both," says Erin Evans, the mother of Rex who was prescribed the ‘atypical’ antipsychotic, Risperdal (risperidone) at age 8. Continue reading →

Oregon Preschoolers Rx ‘adult’ psychotropic drugs_Portland Tribune

In the U.S. the two populations at greatest risk of inappropriate, coercive, dangerous prescribing of highly toxic psychotropic drugs as chemical
restraints are the elderly and children. Continue reading →

“Some of the children were prescribed anti-psychotics, rather than discontinued from ADHD therapy.”

"That thing I’m worried about…where the MedGuide would help, where it might even warrant a black box, if this is common, where somebody hallucinates and then gets put on an anti-psychotic drug. That would really be something worth making sure it doesn’t happen,"
Continue reading →

2.5 Million US Children Prescribed Antipsychotics_ FDA ADHD–ADR Review

The Associated Press reports that a just released study that found that a staggering, two and half million children in the U.S. are being prescribed antipsychotics annually–that’s 40 out of every 1,000 children.
Continue reading →

Another Study Shows: Antipsychotic Trials Biased Towards Sponsor’s Drug

An independent review by a team of German analysts published in the American Journal of Psychiatry confirms that corporate bias is ubiquitous in clinical trials. Continue reading →

Polypharm & New Antipsychotics Not More Beneficial-Just More Expensive

"modern pharmacological treatment may be no more beneficial than older ones, despite their added cost." Continue reading →

Antipsychotic Drugs are Killing patients_Brit J Psychiatry

A major 17-year follow up study published in the British Journal of Psychiatry [1]  found a 2.84 times  (95% CI 2.06–3.90) increased risk of mortality in people with schizophrenia compared to those not so diagnosed, and  with each addition of a neuroleptic (antipsychotic) drug, the risk increased another 2.50.
Continue reading →